Cargando…
Occurrence of senescence-escaping cells in doxorubicin-induced senescence is enhanced by PD0332991, a cyclin-dependent kinase 4/6 inhibitor, in colon cancer HCT116 cells
Cancer treatment induces cellular senescence, and it is considered to be one of the factors that determines treatment outcome. Senescence can be efficiently induced in cultured cells by DNA-damaging drugs, including doxorubicin (DOX), cisplatin and etoposide. Cells in senescence cease proliferation;...
Autores principales: | Kitada, Kunio, Pu, Fengling, Toi, Masakazu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312925/ https://www.ncbi.nlm.nih.gov/pubmed/30655877 http://dx.doi.org/10.3892/ol.2018.9657 |
Ejemplares similares
-
Sorafenib, rapamycin, and venetoclax attenuate doxorubicin-induced senescence and promote apoptosis in HCT116 cells
por: As Sobeai, Homood M., et al.
Publicado: (2022) -
DZNep inhibits the proliferation of colon cancer HCT116 cells by inducing senescence and apoptosis
por: Sha, Mingquan, et al.
Publicado: (2015) -
Radiation-Induced Senescence Reprograms Secretory and Metabolic Pathways in Colon Cancer HCT-116 Cells
por: Nagineni, Chandrasekharam N., et al.
Publicado: (2021) -
Polyploidy Formation in Doxorubicin-Treated Cancer Cells Can Favor Escape from Senescence()
por: Mosieniak, Grazyna, et al.
Publicado: (2015) -
Improved Autophagic Flux in Escapers from Doxorubicin-Induced Senescence/Polyploidy of Breast Cancer Cells
por: Bojko, Agnieszka, et al.
Publicado: (2020)